Pharmacovigilance Services

Pharmacovigilance is a concept defined by the World Health Organization (WHO), specifically "science and activities related to the discovery, assessment, understanding and prevention of adverse reactions or any other drug-related problems", which plays a key role in ensuring the safety of patients' medication. Creative Biolabs helps customers control and understand adverse drug reactions through a variety of methods, including spontaneous reporting, enhanced monitoring and database research. At the regulatory level, these measures include conditional approvals and risk management plans; from a scientific perspective, transparency and increased patient participation are two important factors.

Adverse Drug Reaction (ADR) Monitoring

In recent years, the issue of drug safety has received widespread attention. However, the large number of reported related articles can also cause patients and medical professionals to worry unnecessarily about the use of some drugs. A more serious consequence may be that the patient stops taking prescription drugs, which may lead to a more serious situation. To prevent this, a reasonable drug safety test is required. To help pharmaceutical companies deliver drugs of positive interest to the public, Creative Biolabs provides customers with pharmacovigilance services from the following aspects:

A framework for ADR detection and extraction from social media data.Fig.1 A framework for ADR detection and extraction from social media data. (Sarker, 2015)

Once a pharmacovigilance signal is generated in a clinical trial, it must be validated. Therefore, while data mining can be used to detect potential signals and may imply hypotheses related to those signals, it alone cannot prove a direct causal relationship between drugs and ADE. Other sources of safety data (i.e., clinical trial data, medical literature, etc.) must be analyzed to confirm the clinical significance of the pharmacovigilance signals generated by data mining. If the signal is verified and there is a causal relationship between the drug and the ADE, the FDA may issue a recall, change the drug label, or take the drug out of the market. Creative Biolabs provides clinical pharmacovigilance assessment services that can help you reduce your business risks and unnecessary losses.

If you are interested in our pharmacovigilance services, you can contact us for more details.

Reference

  1. Sarker, A.; et al. Utilizing social media data for pharmacovigilance: a review. Journal of biomedical informatics. 2015, 54: 202-212.
For Research Use Only

Let's Get Started

Contact Us

USA

UK

Follow us on

Copyright © 2022 Creative Biolabs. All Rights Reserved.